LISATA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 79.30K shares, a 1731.72% increase year-over-year.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 4.33K shares, a 67.56% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 13.35K shares, a 83.82% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 82.50K shares.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 7.25K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 79.30K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 79.30K shares 10-Q · filed 2026-05-11 | 79.30K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 4.33K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 17.67K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 17.67K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 4.33K shares 10-Q · filed 2025-05-08 | 17.67K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 13.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 13.35K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -1.15M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | -1.15M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 82.50K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | -1.15M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 1.31M shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-02 | 2.46M shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-03-31 | 1.23M shares 10-Q · filed 2023-08-14 | 2.46M shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | 1.23M shares derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-09 | 1.23M shares 10-Q · filed 2023-05-09 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 7.25K shares 10-K · filed 2022-03-22 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 240.00 shares 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |